JP2024539620A5 - - Google Patents
Info
- Publication number
- JP2024539620A5 JP2024539620A5 JP2024522052A JP2024522052A JP2024539620A5 JP 2024539620 A5 JP2024539620 A5 JP 2024539620A5 JP 2024522052 A JP2024522052 A JP 2024522052A JP 2024522052 A JP2024522052 A JP 2024522052A JP 2024539620 A5 JP2024539620 A5 JP 2024539620A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrrolo
- triazine
- amine
- imidazo
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163254733P | 2021-10-12 | 2021-10-12 | |
| US63/254,733 | 2021-10-12 | ||
| US202263347757P | 2022-06-01 | 2022-06-01 | |
| US63/347,757 | 2022-06-01 | ||
| PCT/US2022/046416 WO2023064366A1 (en) | 2021-10-12 | 2022-10-12 | Pyrrolo[2,1-f][1,2,4]triazines derivatives as inhibitors of dyrk1a |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539620A JP2024539620A (ja) | 2024-10-29 |
| JP2024539620A5 true JP2024539620A5 (enExample) | 2025-10-21 |
Family
ID=84330173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522052A Pending JP2024539620A (ja) | 2021-10-12 | 2022-10-12 | Ｄｙｒｋ１ａ阻害剤としてのピロロ［２，１－ｆ］［１，２，４］トリアジン誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12134625B2 (enExample) |
| EP (1) | EP4415816B1 (enExample) |
| JP (1) | JP2024539620A (enExample) |
| KR (1) | KR20240089275A (enExample) |
| AU (1) | AU2022367222A1 (enExample) |
| CA (1) | CA3234831A1 (enExample) |
| IL (1) | IL312157A (enExample) |
| MX (1) | MX2024004552A (enExample) |
| PY (1) | PY2289204A (enExample) |
| TW (1) | TW202322800A (enExample) |
| UY (1) | UY39979A (enExample) |
| WO (1) | WO2023064366A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023212957A1 (en) * | 2022-01-25 | 2024-08-22 | Kinnate Biopharma Inc. | Inhibitors of cdk4/6 kinase |
| KR20250133646A (ko) * | 2022-11-03 | 2025-09-08 | 바이오스플라이스 테라퓨틱스, 인크. | 4-아미노피롤로[2,1-f][1,2,4]트라이아진 및 이의 제조 및 용도 |
| WO2024211797A1 (en) * | 2023-04-07 | 2024-10-10 | Biosplice Therapeutics, Inc. | Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof |
| CN119019402A (zh) * | 2023-05-24 | 2024-11-26 | 中国科学院上海有机化学研究所 | 作为lrrk2激酶抑制剂的多环化合物及其制备方法和用途 |
| AU2024298476A1 (en) * | 2023-07-26 | 2026-03-05 | Khora Spv 1, Llc | Inhibitors of cdk2/4/6 kinase |
| US20250206746A1 (en) * | 2023-12-22 | 2025-06-26 | Biosplice Therapeutics, Inc. | 4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4164559A (en) | 1977-09-21 | 1979-08-14 | Cornell Research Foundation, Inc. | Collagen drug delivery device |
| US4474752A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
| US4783443A (en) | 1986-03-03 | 1988-11-08 | The University Of Chicago | Amino acyl cephalosporin derivatives |
| US6440102B1 (en) | 1998-07-23 | 2002-08-27 | Durect Corporation | Fluid transfer and diagnostic system for treating the inner ear |
| DE19853299C2 (de) | 1998-11-19 | 2003-04-03 | Thomas Lenarz | Katheter zur Applikation von Medikamenten in Flüssigkeitsräumen des menschlichen Innenohrs |
| US6120484A (en) | 1999-02-17 | 2000-09-19 | Silverstein; Herbert | Otological implant for delivery of medicament and method of using same |
| US6967023B1 (en) | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
| US6648873B2 (en) | 2001-09-21 | 2003-11-18 | Durect Corp. | Aural catheter system including anchor balloon and balloon inflation device |
| ES2364340T3 (es) | 2004-03-30 | 2011-08-31 | Vertex Pharmaceuticals Incorporated | Azaindoles útiles como inhibidores de jak y otras proteína quinasas. |
| JP2008537684A (ja) | 2005-01-24 | 2008-09-25 | ニューロシステック コーポレイション | 内耳およびその他の組織へ治療薬および／またはその他の薬剤を送達するための装置および方法 |
| CA2728559A1 (en) | 2008-07-03 | 2010-01-07 | Exelixis Inc. | Cdk modulators |
| WO2011018894A1 (en) | 2009-08-10 | 2011-02-17 | Raqualia Pharma Inc. | Pyrrolopyrimidine derivatives as potassium channel modulators |
| US8362023B2 (en) * | 2011-01-19 | 2013-01-29 | Hoffmann-La Roche Inc. | Pyrazolo pyrimidines |
| US9260426B2 (en) | 2012-12-14 | 2016-02-16 | Arrien Pharmaceuticals Llc | Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors |
| ME03000B (me) | 2012-12-21 | 2018-10-20 | Plexxikon Inc | Jedinjenja i metode modulacije kinaze i povezane indikacije |
| WO2016010886A1 (en) | 2014-07-14 | 2016-01-21 | Signal Pharmaceuticals, Llc | Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof |
| BR112017027951A2 (pt) * | 2015-06-22 | 2018-08-28 | Ono Pharmaceutical Co., Ltd. | composto inibitório de brk |
| AU2016315881B2 (en) * | 2015-09-03 | 2019-09-19 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Small molecule inhibitors of DYRK1A and uses thereof |
| FR3041640B1 (fr) | 2015-09-30 | 2019-05-17 | Les Laboratoires Servier | NOUVEAUX DERIVES DE PYRROLO[2,3-d]PYRIMIDINE, LEUR PROCEDE DE PREPRATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
| EP3694860A1 (en) * | 2017-10-10 | 2020-08-19 | Syros Pharmaceuticals, Inc. | Pyrrolotriazine compounds and methods of inhibiting tam kinases |
| CA3092828A1 (en) | 2018-03-01 | 2019-09-06 | The Trustees Of Columbia University In The City Of New York | Compounds, compositions, and methods for suppressing toxic endoplasmic reticulum stress |
| US12528810B2 (en) * | 2018-03-01 | 2026-01-20 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Small molecule inhibitors of DYRK/CLK and uses thereof |
| US20220062240A1 (en) | 2018-06-26 | 2022-03-03 | Biosplice Therapeutics, Inc. | Methods of treating cancer using a clk inhibitor |
| CN113015526A (zh) * | 2018-09-19 | 2021-06-22 | 豪夫迈·罗氏有限公司 | 螺环2,3-二氢-7-氮杂吲哚化合物及其用途 |
| JP7503054B2 (ja) | 2018-10-16 | 2024-06-19 | ダナ－ファーバー キャンサー インスティテュート，インコーポレイテッド | Ｌｒｒｋ２の野生型および変異型のアザインドール阻害剤 |
| EP3911317A2 (en) * | 2019-01-17 | 2021-11-24 | BioSplice Therapeutics, Inc. | Methods of treating cartilage disorders through inhibition of clk and dyrk |
| CN112094272A (zh) * | 2019-06-18 | 2020-12-18 | 北京睿熙生物科技有限公司 | Cdk激酶抑制剂 |
| WO2021257863A1 (en) * | 2020-06-19 | 2021-12-23 | Incyte Corporation | Pyrrolotriazine compounds as jak2 v617f inhibitors |
| CA3185649A1 (en) | 2020-07-20 | 2022-01-27 | Bakary-Barry Toure | Indole compounds as androgen receptor modulators |
| TW202330533A (zh) | 2021-10-12 | 2023-08-01 | 美商生物銜接醫療公司 | 7h-吡咯并[2,3-d]嘧啶及其製備及用途 |
| WO2023064349A1 (en) | 2021-10-12 | 2023-04-20 | Biosplice Therapeutics, Inc. | 1h-pyrrolo[2,3-b]pyridines as dyrk1a inhibitors |
| EP4543886A1 (en) | 2022-06-23 | 2025-04-30 | BioSplice Therapeutics, Inc. | 4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof |
-
2022
- 2022-10-12 MX MX2024004552A patent/MX2024004552A/es unknown
- 2022-10-12 KR KR1020247014718A patent/KR20240089275A/ko active Pending
- 2022-10-12 WO PCT/US2022/046416 patent/WO2023064366A1/en not_active Ceased
- 2022-10-12 AU AU2022367222A patent/AU2022367222A1/en active Pending
- 2022-10-12 IL IL312157A patent/IL312157A/en unknown
- 2022-10-12 JP JP2024522052A patent/JP2024539620A/ja active Pending
- 2022-10-12 TW TW111138697A patent/TW202322800A/zh unknown
- 2022-10-12 UY UY0001039979A patent/UY39979A/es unknown
- 2022-10-12 EP EP22801289.4A patent/EP4415816B1/en active Active
- 2022-10-12 CA CA3234831A patent/CA3234831A1/en active Pending
- 2022-10-12 PY PY202202289204A patent/PY2289204A/es unknown
- 2022-10-12 US US17/964,489 patent/US12134625B2/en active Active
-
2024
- 2024-08-15 US US18/806,231 patent/US20250171466A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20240994T1 (hr) | Spoj inhibitora jak i njegova uporaba | |
| US10519177B2 (en) | Heterocyclic compounds and uses thereof | |
| CN118974055A (zh) | 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途 | |
| JP5848251B2 (ja) | オレキシン受容体調節因子としての縮合複素環式化合物 | |
| JP2023550466A5 (enExample) | ||
| JP2019535664A5 (enExample) | ||
| JP2021534166A (ja) | Ｎ−シアノ−７−アザノルボルナン誘導体及びその使用 | |
| TWI662039B (zh) | 用於誘發軟骨生成之化合物及組合物 | |
| RU2009140469A (ru) | Производные пирролопиримидин-7-она и их применение в качестве фармацевтических средств | |
| JP2018514560A5 (enExample) | ||
| ES2807785T3 (es) | Compuestos de heteroarilamina bicíclicos como inhibidores de pi3k | |
| JP2017526726A (ja) | ヘテロ環化合物およびその用途 | |
| JP2017524007A5 (enExample) | ||
| JP2018514552A5 (enExample) | ||
| JP2005506352A (ja) | アデノシンａ２ａ受容体アンタゴニストとしてのイミダゾ（４，３−ｅ）−１，２，４−トリアゾロ（１，５−ｃ）ピリミジン | |
| HRP20171913T1 (hr) | Aminopirimidinilni spojevi kao inhibitori jak | |
| US20140303121A1 (en) | Heterocyclic compounds and uses thereof | |
| JP2024536858A5 (enExample) | ||
| JP2014525397A (ja) | ３環性ヘテロ環化合物及びｊａｋ阻害剤 | |
| CN115989231B (zh) | 一种作为btk抑制剂的化合物及其制备方法与用途 | |
| RU2017137514A (ru) | Имидазопиразиноны в качестве ингибиторов pde1 | |
| RU2019108717A (ru) | Комбинированные средства для лечения, предусматривающего введение имидазопиразинонов | |
| RU2016112952A (ru) | Производные индола и индазола | |
| JP2024521818A5 (enExample) | ||
| RU2020115915A (ru) | Бициклические сульфоны и сульфоксиды и способы их применения |